These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 14740263)

  • 1. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
    Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
    Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
    Abry E; Thomassen IØ; Salvesen ØO; Torp SH
    Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of progesterone receptor status in meningiomas.
    Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
    J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
    Devaprasath A; Chacko G
    Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
    Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
    Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary resected meningiomas: relapses and proliferation markers.
    Kalala JP; Caemaert J; De Ridder L
    In Vivo; 2004; 18(4):411-6. PubMed ID: 15369177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningiomas: correlation of Ki67 with histological grade.
    Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
    Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Skull base meningiomas: a predictive system to know the extent of their surgical resection and patient outcome].
    Morales F; Maillo A; Díaz-Alvarez A; Merino M; Muñoz-Herrera A; Hernández J; Santamarta D
    Neurocirugia (Astur); 2005 Dec; 16(6):477-85. PubMed ID: 16378129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can recurrence of meningiomas be predicted?
    Kalala JP; Benoit D; De Ridder L
    Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index.
    Nakaya K; Chernov M; Kasuya H; Izawa M; Hayashi M; Kato K; Kubo O; Muragaki Y; Iseki H; Hori T; Okada Y; Takakura K
    Minim Invasive Neurosurg; 2009 Oct; 52(5-6):216-21. PubMed ID: 20077361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
    Shayanfar N; Mashayekh M; Mohammadpour M
    Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.